Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosome
- 1 October 1992
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 2 (2) , 128-131
- https://doi.org/10.1038/ng1092-128
Abstract
A predisposing gene for breast and ovarian cancer has recently been mapped to chromosome 17q12–21. If this gene is a tumour suppressor gene, allele losses would be expected in the tumours of affected family members and the losses should affect the wild–type chromosome, reflecting the need for inactivation of the wild–type allele at the predisposing locus. In four multiple case breast–ovarian cancer families, we have found that in each of nine tumours which showed allele losses, the losses were from the wild–type chromosome. This suggests that the putative ‘breast–ovarian’ cancer gene is indeed a tumour suppressor gene.Keywords
This publication has 6 references indexed in Scilit:
- Familial breast-ovarian cancer locus on chromosome 17q12-q23The Lancet, 1991
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990
- Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locusCell, 1990
- Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila developmentNature, 1989
- Gene losses in human tumoursNature, 1988
- Evidence for a Novel Gene Associated With Low Tumor Metastatic PotentialJNCI Journal of the National Cancer Institute, 1988